Drug Trial Radar · NCT05358886
A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
171
Actual
Start
Nov 1, 2022
Primary completion
Jul 18, 2025
Study completion Jul 18, 2025
Sponsor
- Lead sponsor
- Tetra Discovery PartnersIndustry
- Sponsor type
- Industry
- First posted
- May 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome
Conditions
- Fragile X Syndrome
Interventions
BPN14770/ zatolmilastDrug
25mg BID BPN14770
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- National Institutes of Health Toolbox Cognitive Battery cognition crystallized composite score (NIH-TCB CCC)Time frame: 13 Weeks
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Amnova Clinical Research
Irvine, California
Thompson Autism & Neurodevelopment Center - CHOC
Orange, California
UC Davis Health System
Sacramento, California
Children's Hospital Colorado
Aurora, Colorado
University of Miami
Miami, Florida
Emory University School of Medicine
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Kennedy Krieger Institute
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
University of Massachusetts Medical School
Worcester, Massachusetts
Icahn School of Medicine at Mount Sinai Hospital
New York, New York
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio
Suburban Research Associates
Media, Pennsylvania
Clinic for Special Children
Strasburg, Pennsylvania
Greenwood Genetic Center
Greenville, South Carolina
University of Utah and Primary Childrens Hospital
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.